Aurobindo Pharma reported INR9.21B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Cipla INR 5.55B 1.21B Mar/2026
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Dr.Reddys Laboratories INR 2.21B 9.89B Mar/2026
Hindustan Unilever INR 29.92B 36.15B Mar/2026
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
UPL INR 10.61B 6.65B Mar/2026